- Home
- CBNK vs NBY Comparison
CBNK vs NBY Comparison
Compare CBNK & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CBNK | NBY |
|---|---|---|
| Founded | 1974 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.4M | 398.2M |
| IPO Year | 2018 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CBNK | NBY |
|---|---|---|
| Price | $29.60 | $14.65 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $34.00 | N/A |
| AVG Volume (30 Days) | 44.6K | ★ 3.2M |
| Earning Date | 01-22-2026 | 11-07-2025 |
| Dividend Yield | 1.62% | ★ 5.42% |
| EPS Growth | ★ 26.24 | N/A |
| EPS | ★ 2.95 | 0.47 |
| Revenue | ★ $222,152,000.00 | $10,302,000.00 |
| Revenue This Year | $44.59 | $23.91 |
| Revenue Next Year | $6.44 | $32.05 |
| P/E Ratio | ★ $10.02 | $573.91 |
| Revenue Growth | 40.71 | ★ 390.34 |
| 52 Week Low | $24.69 | $0.46 |
| 52 Week High | $36.40 | $19.95 |
Technical Indicators
Market Signals| Indicator | CBNK | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 64.49 | 68.02 |
| Support Level | $27.78 | $10.42 |
| Resistance Level | $29.03 | $19.95 |
| Average True Range (ATR) | 0.52 | 3.14 |
| MACD | 0.12 | 0.53 |
| Stochastic Oscillator | 84.14 | 67.14 |
Price Performance
Historical ComparisonAbout CBNK Capital Bancorp Inc.
Capital Bancorp Inc is a bank holding company. The company through its holdings operates as a commercial-focused community bank that serves businesses, not-for-profit associations, and entrepreneurs throughout the region. The bank operates through four divisions including Commercial Banking, Capital Bank Home Loans, OpenSky, and Windsor Advantage, and also operates in five business segments: commercial banking; mortgage banking; credit cards; government loan servicing; and corporate activities.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.